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Background:  The aim of this study was to examine the cardiac function and transcriptional response of the heart to 
propofol after ischemia-reperfusion.
Methods:  Rat hearts were Langendorff-perfused using the modified Krebs-Henseleit buffer, and took 20 min 
stabilizing periods, 40 min ischemia periods, and then 120 min reperfusion period.  The hearts were divided into 5 
groups; Control: 180 min perfusion after stabilization, Ischemic: 40 min global ischemia after stabilization, followed 
by 120 min reperfusion, Pre: 2 μM propofol treatment was preformed only before ischemia, Post: 2 μM propofol 
treatment was performed only during reperfusion after ischemia, Pre/Post: 2 μM propofol treatment was performed 
both before and after ischemia.  The measurement for cardiac performances, such as left ventricular developed 
pressure (LVDP), rate of left ventricular pressure generation (dP/dt), heart rate, and coronary flow were obtained. The 
expression profiles of isolated mRNA were determined by using Agilent microarray and real time-polymerase chain 
reaction (RT-PCR) was used to confirm the microarray results for a subset of genes. 
Results:  The Post group showed better LVDP and dP/dt than the Ischemic group.  But there were no significant 
differences in heart rate and coronary flow among the groups.  On the results of RT-PCR, the expressions of Abcc9, 
Bard1, and Casp4 were increased, but the expressions of Lyz, Casp8, and Timp1 were decreased in the Post group 
compared with the Ischemic group.
Conclusions:  This study suggests that 2 μM propofol may provide cardioprotective effect, and modulate gene 
expression such as apoptosis, and KATP ion channel related-genes during reperfusion in the isolated rat hearts.  (Korean 
J Anesthesiol 2010; 58: 153-161)
Key Words:  Ischemia, Microarray, Propofol, Rat heart, Real time-polymerase chain reaction, Reperfusion.
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Introduction
    Reactive oxygen species (ROS) such, as superoxide anions, 
hydroxyl radicals, and hydrogen peroxide, which are generated 
after ischemia/reperfusion injuries, play an important role in 
reperfusion injuries, including myocardiac stunning, cardiac 
death, dysrrhythmia, and chronic cardiac disease. ROS are 
now known to induce apoptosis and activate guanylate cyclase 
and transcriptional factors that act as secondary messengers, 
both mechanisms which result in cardiac cell death. Therefore, 
cardioprotective strategies aimed at alleviating or preventing 
ROS production may be targeted during the ischemia/
reperfusion of cardiac surgery [1-4]. 
    Propofol, which is frequently used in cardiac anesthesia, 
has a chemical structure similar to phenol-based free radical 
scavengers such as vitamin E, a scavenger that is responsible for 
antioxidant activity. The cardioprotective effects of propofol are 
still debated and unclear. Some previous in vivo/vitro studies 
have suggested that propofol, when not administered during 
reperfusion and before the ischemic period, has protective 
effects [5,6]. However, in some clinical studies, different results 
showed that propofol, when given only during reperfusion, had 
cardioprotective effects. Various mechanisms to support these 
findings are: the reduction of free radicals [7,8], the inhibition 
of the myocardial calcium influx [9], and the suppression of 
neutrophil activity [10]. However, Ebel et al. did not provide a 
description of the cardioprotective effects of propofol when 
administered during reperfusion [11]. 
    DNA microarrays are a powerful genetic technology that can 
be used to measure changes in expression levels, detect single 
nucleotide polymorphisms (SNPs), and genotype or resequence 
mutant genomes. Therefore, arrays have overcome the limited 
information obtained by southern or northern methods, 
dramatically accelerated many types of investigations, and have 
been expected to explore the key cellular events in ischemia/
reperfusion injury and preconditioning. Investigations of 
ischemic preconditioning effects on the gene expression 
patterns in rat hearts demonstrated that a number of genes with 
significantly altered gene expression were significantly altered; 
however, very little is known about the effects of propofol on the 
gene expression patterns after ischemic-reperfusion in isolated 
rat hearts [12,13]. 
    The aim of this study was to examine the cardiac function and 
transcriptional response of the heart to propofol after ischemia-
reperfusion.
Materials and Methods
    The study was performed in accordance with the IACUC 
(Institutional Animal Care and Use Committee) of Korea 
University. Male Sprague-Dawley rats (250-300 g: Charles 
River Laboratory Inc., Tokyo, Japan) were first anesthetized 
with ketamine 10 mg/100 g followed by an intraperioneal 
hepariniziation of the hearts with 1,000 IU of heparin. Each 
heart was quickly removed and perfused in the Langendorff 
perfusion system (Hugo-Sachs Electronik, March-Hugstetten, 
Germany). Retrograde perfusion was initiated with modified 
Krebs-Henseleit buffer, which was saturated with 95%O2-5% 
CO2 and contained the following ingredients: NaCl 118 mM, 
KCl 4.7 mM, MgSO4 1.64 mM, KH2PO4 1.18 mM, NaHCO3 24.88 
mM, glucose 5.55 mM, CaCl2 2.52 mM, Na-EDTA 0.5 mM. All 
of the hearts were perfused at a constant pressure of 60 mmHg. 
The pH and temperature of the inflow were maintained at pH  = 
7.4 ± 0.22 and 37 ± 0.2
oC respectively using a circulating water 
bath system (Jeio Tech, Model WBC 1520A). A warm distilled 
water-filled, balloon-tipped catheter with an external diameter 
of 3 mm was inserted into the left ventricle through the left 
atrium. Left-ventricular end-diastolic pressure was adjusted to 
5-10 mmHg by adjusting the balloon volume. Coronary flow 
was measured using collected coronary sinus effluent that was 
collected from the pulmonary artery cannula. The distal end of 
the catheter was connected to a performance analyzer (Grass 
Model No. 79 Polygraph; Grass Instrument Division, Astro-
Med, West Warwick, RI, USA) using a pressure transducer. To 
determine the left ventricular developed pressure (LVDP), 
the maximum and minimum values of the rate of the left 
ventricular pressure generation (dP/dt), heart rate, and 
coronary flow continued to be simultaneously recorded using 
software (Acknowledge program for windows version 3.5.2, 
Biopac system Inc., USA). 
    Animals were randomized into the following 5 groups after 
equilibration for 20 min stabilizing periods: Control, 180 min 
perfusion after stabilization; Ischemic, 40 min global ischemia 
after stabilization, followed by 120 min reperfusion; Pre, 2 μM                       
propofol treatment was preformed only before ischemia; 
Post, 2 μM propofol treatment was performed only during 
reperfusion after ischemia; Pre/Post, 2 μM propofol treatment 
was performed both before and after ischemia. Left ventricular 
developed pressure (LVDP), maximum and minimum rate 
values for the left ventricular pressure generation (dP/dtmax, 
dP/dtmin), heart rate, and coronary flow were measured and 
compared after a reperfusion period of 120 min. 
    After the protocols were completed, the left ventricular tissue 
was quickly frozen in liquid nitrogen and stored in RNAlater 
Ⓡ
(Ambion
Ⓡ Foster City, CA, USA) at -80
oC. Frozen heart tissue 
was powdered and homogenized twice using a rotator-stator 
and a 23 G needle after adding 1 ml of TRIzol (Invitrogen, USA) 
and vortexing for about 15 sec. Residual protein was removed 
with chloroform (200 μg), mixed, vortexed, placed at room 
temperature for 2 min, and centrifuged for 15 min at 14,000 rpm 155 www.ekja.org
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and 4
oC. The supernatant aqueous phase was precipitated in the 
same volume of binding buffer by vortexing 10 times followed 
by an incubation at room temperature for 10 min and then 
centrifuging for 10 min at 14,000 rpm and 4
oC. The RNA pellet 
was finally extracted by adding 75% ethanol-treated DEPC and 
centrifuging for 5 min at 10,000 rpm and 4
oC. The total RNA 
was extracted after removing the ethanol, the pellet was dried 
at room air temperature, and dissolved in RNase-free water. 
The resulting total RNA pellet was dissolved in ultra pure water 
and the sample quantity (260 nm) and quality (280 nm) were 
measured by a spectrophotometer. The purification and quality 
of the total RNA was 2.0 ± 0.1 of the 260/280 ratio and more than 
1.9 of the (28s/18s) rRNA ratio as measured using the Agilent 
2100 Bioanalyzer (Agilent Technology, USA), respectively. 
cDNA was synthesized from the total RNA with the High-
Capacity cDNA reverse transcription kit (Applied Biosystems, 
USA). Real time-polymerase chain reaction (RT-PCR), by 
which gene expressions were quantified, was performed with 
the SYBR Green I protocol (Takara, Japan) according to the 
manufacturer's instructions. PCR cycling conditions were 
performed in a total volume of 20 μg, after incubation for 5 min 
at 70
oC, and cooling for 1 min. The used primer sequences were 
listed in Table 1, 2.
    All values are expressed as the mean ± SD or SE. SPSS (ver. 
13.0) was used for the statistical analysis. Cardiac function, 
coronary flow, and signal intensities of individual transcripts 
from the microarray were confirmed by RT-PCR and were 
compared among groups by one-way ANOVA, followed by 
Turkey's test for multiple comparisons. Cardiac function and 
coronary flow were compared between groups using a paired t 
test. Statistical significance was established at P values < 0.05.
Table 1. Biologic Function of Primers used for Quantitative Real Time-Polymerase Chain Reactions
Gene symbol Biologic & molecular function
Casp8 Caspase-8 Apoptosis, macrophage differentiation
Birc3 Inhibitor of apoptosis protein 1 Anti-apoptosis
Timp1 Tissue inhibitor of 
metalloproteinase 1
Metalloendopeptidase inhibitor activity
Casp4 Caspase-11 Apoptosis, caspase activation, inflammatory response, proteolysis
Lyz Lysozyme Cell wall catabolism, carbohydrate 
Metabolism
Bard1 BRCA 1 associated ring domain 1 Transcription factor activity, DNA binding; RNA binding,; zinc ion binding
Abcc9 ATP-binding cassette, sub-family 
C (CFTR/MRP), member 9
Potassium ion transport, ATP binding, ATPase activity, ATPase activity coupled   
  to transmembrane movement of substances, receptor activity, sulfonylurea     
  receptor activity
Gna11 Guanine nucleotide binding protein, 
alpha 11
G-protein coupled receptor protein signaling pathway, signal transduction
Itga1 Integrin alpha 1 Cell adhesion, cell-matrix adhesion, receptor activity, magnesium ion binding
Slick Sodium- & chloride- activated ATP- 
  sen  sitive potassium channel
ATP binding, intracellular sodium activated potassium channel activity
Table 2. Primers Sequence used for Quantitative Real Time-Polymerase Chain Reactions
Gene symbol Primer sequence
Casp8 GAACATGGGAAAGCAGATGCCACAGCCCATCTTCACACTACGGAAGAAGCTCTTCTTCCCTCCTAACTGA
Birc3 CGTAAAACAGAAACCACACACCTTGCAGGCAAGGACACTGATCGATACTGTATTAGCGAAAGGAAACACC
Timp1 TTCATGGGTTCCCCAGAAATCATCGAGACCACCTTATACCAGCGTTATGAGATCAAGATGACTAAGATGC
Casp4 AAGTATTAATTCCCAGATGCCCACCATTGATCGGGCAACCTTGACAAGATATTTCTACCTCTTTCCTGGC
Lyz GCTGCAGGATGACATCACTCAAGCCATACAATGTGCGAAGAGAGTTGTGAGGGATCCCCAAGGCATTCGA
Bard1 GGCGCGTGGTTTGTGAGAACACGGCCATTGTGATGTTTGATCACTCTCGCTTTTATGGATAGGTAGAACC
Abcc9 CCTTCGACTGTCTACTTCTAACCTATCCATGGGCGAGATGACCCTGGGACAGATCAACAACTTGGTTGCC
Gna11 GACTTTTGAGCATCAGTATGTGAACGCCATCAAGACACTGTGGAGTGACCCTGGTGTCCAGGAGTGCTAC
Itga1 GTAGACCCCGGAGCCTTGAGGACCCCTTTGGCATCAACTCTGGGAAGAAAATGACAATATCGAAGTCTGA
Slick GCAGTCACCTGAACAGTGGCAGAAGACGTATGGGAGGTGCTCAGGAAATGAAGTCTACCACATCGTTCTG156 www.ekja.org
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Results
    Under baseline conditions, the hemodynamic variables were 
similar in all groups. Fig. 1 shows coronary flow, left ventricular 
developed pressure (LVDP), dP/dtmax, dP/dtmin measured 
at baseline and immediately after the 120 min reperfusion 
period in isolated rat hearts. In left ventricular developed 
pressure (LVDP), dP/dtmax, dP/dtmin, we found a significant 
difference in the Post group compared with the Ischemic 
group (P < 0.05). Coronary flow that developed during the 
baseline and reperfusion periods in the isolated rat hearts was 
not significantly different among the groups. One of the Post 
groups has increased values compared with one of the Ischemic 
and Pre groups, but we found no significant difference among 
the groups. The heart rate that developed during baseline 
and reperfusion period in the isolated rat hearts was not 
significantly different among the groups. In contrast, heart rate 
during reperfusion was significantly decreased compared with 
its respective baseline values between all groups (P < 0.05). 
LVDP in the Post groups was significantly increased compared 
with the Ischemic group (142.6 mmHg vs 101.2 mmHg). LVDP 
in the Ischemic, Pre, and Pre/Post groups, but not the Post 
Fig. 1. Heart rate, left ventricular developed pressure (LVDP), 
coronary flow, dP/dtmax, dP/dtmin measured at baseline and imme-
diately after 120 min reperfusion period in the isolated rat hearts. 
There is a significant difference in the Post group compared with 
the Ischemic group. The values are mean ± SD. Control: 180 min 
perfusion after stabilization, Ischemic: 40 min global ischemia after 
stabilization, followed by 120 min reperfusion, Pre: propofol treat-
ment was preformed only before ischemia, Post: propofol treatment 
was performed only during reperfusion after ischemia, Pre/post: 
propofol treatment was performed both before and after ischemia. 
*Significantly different from its respective baseline value (P < 0.05), 
†Significantly different from the Ischemic group (P < 0.05).157 www.ekja.org
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group during reperfusion was significantly decreased. We 
found that the rate of the left ventricular pressure generation, 
which represents dP/dtmax for myocardiac systolic function and 
dP/dtmin for myocardiac diastolic function, was significantly 
different in the Post group (dP/dtmax; 2,000.9 mmHg/s, dP/
dtmin;-1,534.6 mmHg/s) compared with the Ischemic group 
(dP/dtmax; 3,060.2 mmHg/s, dP/dtmin; -2,175.6 mmHg/s) (P 
< 0.05). Finally, we found that the dP/dtmax and dP/dtmin that 
developed during the baseline and reperfusion periods was not 
significantly different among the groups except for in the Post 
group.
    Fig. 2 shows the hierarchical clustering of the total 
experiments. The Ischemic group contains up-regulated genes 
(red) in the upper panel, whereas down-regulated genes (green) 
are located in the lower panel, compared with the Time-
matched control group. 
    With regard to the microarray results, Table 3, 4 demonstrate 
that the Ischemic group up-regulated 1864 genes by 2.0 fold 
or greater. These genes are composed of about 509 genes 
that are related to cell proliferation and response to external 
stimuli, whereas 1350 genes were down-regulated from the 
Pre group by 2.0 fold or greater, a finding that shows similar 
gene expression patterns with the Ischemic group. When the 
Post group was compared with the Time-matched control 
group, 1994 genes were up-regulated by 2.0 fold or greater. 
This group is composed of genes related to ion transport and 
cell communication, whereas 998 genes were down-regulated 
by 2.0 fold or greater, which were related to apoptosis, the 
protein kinase cascade, and cytokine production. All genes that 
had significantly different expression between the Post and 
Ischemic groups with regard to cardiac functional parameters 
were assesses by RT-PCR using 10 primers, except for the Slick 
and Gna11 genes. Specifically, the Abcc 9 gene that is related 
to the KATP ion channel was significantly increased, and the Lyz 
gene is significantly decreased compared to the Abcc 9, Itga 
1, Lyz, and Birc 3 genes, which were up-regulated in the Post 
group by 2.0 fold or greater (P < 0.05). In addition, the Bard1 
and Casp4 genes are significantly increased, while the Casp8 
and Timp1 genes are significantly decreased compared to the 
Table 3. Biologic Function of Genes with Increased Expression in Response to Propofol during Reperfusion as Compared with Time-matched 
Control Group
No.
of genes
Function/description No.
of genes
Function/description
Cell growth (13) Ion channel (6)
3
1
3
2
2
2
Intracellular signal transduction
Angiogenesis
Ion transport
Cytoskeleton organization and biogenesis
AHNAK nucleoprotein
Others
1
2
1
2
Calcium channel, glutamate receptor, ionotropic
Calcium channel, voltage-dependent, L type
Potassium channel, inwardly-rectifying channel 
ATP-sensitive potassium channel
Defense immunity (8) Metabolism (10)
1
2
1
1
3
Response to oxidative stress
DNA repair
Acute phase response
Cellular defense response
Others
1
1
3
1
4
Carbohydrate metabolism
Cell adhesion
Amino acid metabolism
Regulation of fatty acid metabolism
Others
Fig. 2. Total experiments hierarchical clustering. The upper panel 
demonstrates up-regulated genes (red) compared with the Time-
matched control group, whereas the lower panel shows down-
regulated genes (green) compared with the Time-matched control 
group. Ischemic: 40 min global ischemia after stabilization, followed 
by 120 min reperfusion, Pre: propofol treatment was performed only 
before ischemia, Post: propofol treatment was performed only dur-
ing reperfusion after ischemia, Pre/post: propofol treatment was 
performed both before and after ischemia.158 www.ekja.org
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Bard1, Casp4, and Timp1 genes, which were down-regulated in 
Post group by 2.0 fold or greater (Fig. 3, P < 0.05).
Discussion
    We looked into the effect propofol has on gene expression and 
the function of a Langendorff heart in a Sprague-Dawley rat with 
an ischemia-reperfusion injury. As a result, in comparison with 
the Ischemic group, the Post group dosed with 2 μM propofol 
during reperfusion showed excellent results in myocardial 
function and in the different aspects of gene expression. 
    In this study, as an indicator of myocardial function for an 
ischemia-reperfusion injury of propofol, we observed that 
the left ventricular developed pressure and we also noted the 
minimum and maximum rate of change of left ventricular 
pressure. As a result of the experiment, there has been an 
improvement of systolic dysfunction examined through left 
ventricular-developed pressure and the maximum rate of 
change of left ventricular pressure in the Post group dosed of 
propofol in the reperfusion interval. It also showed a significant 
improvement in Post group, compared to the Ischemic group, in 
the diastolic function of the myocardium examined through the 
minimum rate of change of left ventricular pressure. However, 
in the Pre group dosed before ischemia and the Pre/Post group 
dosed both before ischemia and during the reperfusion interval, 
there was no improvement shown in myocardial function 
compared to the Ischemic group. Such a result implies that 2 μM 
propofol has a protection function on a reperfusion interval 
injury than myocardial injury during the ischemic interval. It is 
estimated that the dosage of propofol before ischemic offsets 
certain effects of the propofol during reperfusion. Experiments 
that have shown benign results for myocardial preservation of 
certain propofol [5,6], were resulted by a higher than clinical 
concentration dosing capacity right before ischemia or only 
for a short period during reperfusion. Researchers, including 
Kokita et al. [5], indicated that 25-50 μM propofol improved 
Table 4. Biologic Function of Genes with Decreased Expression in Response to Propofol during Reperfusion as Compared with Time-matched 
Control Group
No.
of genes Function/description No.
of genes Function/description
Apoptosis (23) Transcription regulation (6)
2
2
2
5
2
1
1
8
Janus kinase 2
Interleukin 1 alpha
TNF receptor superfamily
Caspase
Interferon, beta 1
Tissue inhibitor of metalloproteinase 1
Death associated protein kinase 1
Others
1
1
1
3
NF of kappa light chain gene enhancer
Homeo box, msh-like 1
cAMP responsive element binding protein 
Others
Signal transducer (16) Cell motility (8)
1
1
1
1
4
2
1
5
Lectin, galactoside-binding protein
Endothelin 1
Hemopoietic cell kinase
Epidermal growth factor receptor
Olfactory receptor
GTP-binding protein
Mitogen-activated protein kinase
Others
1
1
1
1
4
Chemokine ligand 3
Intercellular adhesion molecule 1
ATPase
Trophoblast glycoprotein
Others
Fig. 3. Confirmation of microarray by means of real time-poly  merase 
chain reactions (RT-PCR) in the Post group compared with the Isch-
emic group. The two genes of 10 primers, which were unde  tectable in 
RT-PCR, were excluded. GADPH was used to normalize mRNA lev-
els. Data are presented as mean ± SE (n = 3 for each groups). Abcc9: 
ATP-binding cassette, sub-family C (CFTR/MRP), member 9, Itga1: 
integrin alpha 1, Lyz: lysozyme, Birc3: inhibitor of apoptosis protein 
1, Bard1: BRCA 1 associated ring domain 1, Timp1: tissue inhibitor 
of metalloproteinase, Casp4: caspase-11, Casp8: caspase-8. *Signifi-
cantly different from the Ischemic group (P < 0.05).159 www.ekja.org
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myocardial function after reperfusion when dosed before 
ischemia. Researchers, including Ko et al. [6], indicated that 
30 μM propofol recovered myocardial function, and 100 μM 
propofol reduced the ischemic contraction level. Researchers, 
including Kawano et al. [14], indicated that in order for propofol 
to suppress the KATP ion channel and display the myocardial 
protection effect, a concentration of more than 31 μM has to 
be used and that propofol at less than 2 μM, which is clinical 
capacity, did not affect the KATP ion channel. However with the 
plasma concentration of propofol used clinically being 0.7-20 μg/
ml [9], its binding with protein is 97-99%, and the concentration 
of the free drug that displays the actual effect is 0.006-0.544 μg/ml 
[15]. Therefore, 2 μM propofol (0.35 μg/ml) used in this research 
is a smaller amount compared to previous research, but it is of 
huge significance since it has proven the myocardial protection 
effect after a consistent dosage with clinical concentrations for 
120 minutes of reperfusion. There is little research assessing 
myocardial function during the medication period using 
propofol at clinical capacity. In conventional research, unlike 
propofol anesthesia used in clinical cardiac anesthesia, 
myocardial function has been assessed by dosing before 
ischemia or during a short period of reperfusion or by dosing 
concentrated propofol from before ischemia to the whole 
period of reperfusion. Further research is required in regards 
to the cause of such differences in the myocardial protection 
effect, according to the medication period.
    ROS mediated path, which was activated during ischemia-
reperfusion injury, increases changes in gene expression 
and enzyme system activity and produces cytocaine, which 
increases cell to adapt to stress, cell proliferation and apoptosis 
and affects in multiple cell types. This causes protein synthesis 
by activating cell surface receptors and transcription factor [3,4]. 
    In the case of ischemic preconditioning and inhalation 
anesthetic, it is reported that action potentials are reduced by 
hyper polarization of heart membrane through activating KATP 
ion channel of mitochondria and sarcolemma, directly and 
indirectly towards ischemic-reperfusion injury. This displays 
myocardial protection effect by suppressing the calcium 
increase within cells. However, intravenous anesthetics such as 
propofol are known not to have a myocardial protection effect 
similar to ischemic preconditioning or inhaled anesthetics [16]. 
Even so, protection mechanisms of propofol for myocardium 
occurred during ischemia and reperfusion is still open to 
dispute. It is considered important because it is an anesthetic 
often used in cardiac anesthesia.
    In this research, the gene expression of Post group had 
excellent effects in functional recovery of myocardium after 
ischemia-reperfusion. Unlike the Ischemic group, genes in 
relation to ion channel, cell defense, cell differentiation and 
metabolism, which are conflicting aspects, have increased. 
Genes in relation to apoptosis, transcriptional regulation, signal 
transduction and cell movement have reduced, which could 
be verified in RT-PCR results. While gene expression of Abcc9, 
Bard1 and Casp4 has increased significantly in the Post group, 
compared to Ischemic group, gene expression of Lyz, Timp1 
and Casp8 has reduced significantly. 
    The Abcc9 gene is associated with sulfonylurea receptor, 
which is one of the ATP sensitive potassium channels, similar 
to the KATP ion channel. It has increased 1.5 times more in 
the Ischemia group than the Post group. The role of the KATP 
ion channel during ischemia-reperfusion injury is known 
to optimize energy production of mitochondria, to reduce 
calcium overload, and to have a myocardial protection effect 
through increasing protein and gene expression that involve in 
endogenous myocardial cell protection [17]. Therefore, using 
medication that can open the KATP ion channel for myocardial 
ischemic injury could possibly be a new therapeutic strategy 
[18]. Halogenated inhalation anesthetics, such as isoflurane 
[19], sevoflurane [20], and deflurane [21] during ischemia-
reperfusion injury, displays myocardial protection by activating 
the KATP ion channel; however, intravenous anesthetic such as 
propofol are known not to affect KATP ion channel, or to block, 
dose-dependently, KATP ion channel in higher concentrations 
[14]. However in this research, 2 μM propofol, which is the 
clinical concentration dosed during reperfusion, has increased 
in gene expression of the KATP ion channel, displaying different 
results compared to previous research. Detailed mechanism 
in regards to such differences in results is unknown, but it is 
estimated that propofol may control by switching the level of 
gene expression of the KATP ion channel according to its dosage. 
Further research in relation to this is required.
    Reduction in the Lyz gene expression, similar to conventional 
research results, propofol during ischemia-reperfusion injury 
is thought to have an effect on myocardial function through 
reducing formation of ROS and function of neutrophil and 
through improving metabolic disorders.
    Results show that the Casp4 gene, a gene involved in 
apoptosis, has increased while the Timp1 gene and Casp8 genes 
have decreased. Apoptosis occurs not only from diverse normal 
physiological stimuli but also from adverse environmental 
conditions and cytotoxic substances. Recently, apoptosis is 
known to be a series of processes in relation to genes. Two 
major paths are involved. Firstly, there is a downstream caspase 
cascade that occurs with the activation of the Casp9 (caspase-9) 
gene, an initiator of proteinas through damage of mitochondria 
[22]. Secondly, there is a path where receptors form groups in a 
death-receptor path, forming death-inducing signaling complex 
and finally activating the Casp8 and Casp3 (caspase-3) genes 
[23]. According to Scarabelli et al. [24], it is proven that apoptosis 
after ischemia-reperfusion injury is not a simple reaction, 160 www.ekja.org
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but is a process that occurrs when the aforementioned paths 
activate differently. In the case of the Casp8 gene, as it gradually 
increases from the last half of reperfusion and involves in 
apoptosis, if the selective inhibitor that targets the Casp8 gene 
is used, it is said to minimize cell injury. In this research, as for 
the reduction in the Casp8 gene expression displayed in the 
Post group compared to the Ischemic group, propofol may have 
worked as an inhibitor of Casp8 in apoptosis path. However, in 
the Post group, unlike the Casp8 and the Casp4 gene expression 
in relation to apoptosis has increased. The functional role of 
the Casp4 gene in the process of apoptosis during ischemia-
reperfusion injury is not clearly known. Different results of 
gene expression of the Casp8 and Casp4 genes are statistically 
similar; there is not much of a significant difference in the 
Ischemic group and the Post group. Therefore, it is estimated 
that propofol has a mediating or controlling function in the 
apoptosis process during ischemia-reperfusion injury, but it 
does not have a greater impact. 
    The Timp1 gene is known not only to maintain and control 
homeostasis and integration of extra-cellular matrix, but it is 
also known to play an important role in cell growth, apoptosis, 
and angiogenesis. It protects tissue indirectly by lowering 
levels of matrix metalloproteinases, which is formulated when 
stress occurs [25]. However, just like the Casp4 gene, since the 
difference in two groups is not considerable, it is difficult to 
conclude that propofol plays an important role for the Timp1 
gene expression in the ischemia-reperfusion model.
    As a limitation of this research, since it is an in vitro 
experiment done with a Sprague-Dawley rat and a model where 
ischemic injury has been surgically-created in a normal heart, it 
can display different results in a heart that has actual ischemic 
disease. Also, since warm ischemia is maintained at 37
oC, a pH 
level of 7.4 was used, using Krebs solution and isothermic water 
bath, variations in perfusion fluid instead of cold ischemia that 
is used clinically and since the Langendorff model was used, 
and it does not contain protein and is deprived of neutroghil, 
humoral hormone or autonomic nervous system effects, it 
cannot be applied in an actual clinic. Further research targeting 
in vivo experiments is required. Since this experiment does not 
quantize protein, which is an end product, but is the research of 
gene expression involved in every process, there is difficulty in 
estimating that all genes expressed will compose protein.
    In conclusion, in the ischemia-reperfusion model using the 
Langendorff heart of a Sprague-Dawley rat, 2 μM propofol 
dosed during reperfusion has myocardial protection effect. 
By observing the effect that propofol has on gene expression 
through microarray and RT-PCR, gene expression in relation to 
apoptosis, such as the Casp8 gene, has been reduced. However, 
it does affect the apoptosis process since there was an increase 
in expression of the Casp4 gene and reduction in the Timp1 
gene. It is estimated, however, that one of most probable 
mechanisms of propofol is the myocardial protection effect 
mainly through the KATP ion channel rather than the function 
that suppresses cytotoxicity such as apoptosis. The relevance 
of the cardio protective effect on the gene, which is involved in 
KATP ion channel and apoptosis during ischemia-reperfusion 
injury, is an important outcome of this research. Which exact 
mechanism is unknown but definitely will help to determine 
the mechanism for the cardio protective effect of propofol, 
which is still controversial. 
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